Coming off Saxenda (liraglutide 3.0 mg) is a significant decision that requires careful planning to maintain the weight loss and health benefits achieved during treatment. Saxenda is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related conditions. People discontinue treatment for various reasons including reaching weight goals, experiencing side effects, cost considerations, or inadequate response. Understanding what happens when you stop and how to manage the transition can help minimise weight regain and preserve metabolic improvements. This article provides evidence-based guidance on safely discontinuing Saxenda and maintaining long-term weight management success.

Understanding Saxenda and Why People Stop Treatment

Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidaemia. It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a naturally occurring hormone that regulates appetite and food intake. Saxenda slows gastric emptying, increases feelings of fullness, and reduces hunger signals in the brain, thereby supporting calorie reduction and weight loss when combined with a reduced-calorie diet and increased physical activity.

People discontinue Saxenda for various reasons, and understanding these can help inform decisions about stopping treatment. Common reasons include:

• Achievement of weight loss goals – some patients reach their target weight and wish to maintain it without ongoing medication

• Side effects – gastrointestinal symptoms such as nausea, vomiting, diarrhoea, or constipation can be persistent and troublesome for some individuals

• Cost considerations – Saxenda has restricted availability on the NHS (through specialist weight management services under NICE TA664) and private prescription costs can be substantial

• Inadequate response – NICE guidance recommends discontinuing treatment if less than 5% body weight is lost after 12 weeks at the maintenance dose

• Pregnancy – Saxenda is contraindicated in pregnancy and should be discontinued if pregnancy occurs or is planned

• Medical concerns – development of conditions where caution is advised, such as pancreatitis or severe renal impairment

Saxenda is also contraindicated during breastfeeding and in people with hypersensitivity to liraglutide or any of the product's ingredients. It is not recommended for those under 18 years of age.

It is essential to discuss your reasons for stopping with your prescribing clinician, as they can provide personalised advice and support for the transition period. Abrupt cessation without a plan may increase the risk of weight regain and loss of metabolic benefits achieved during treatment.

What Happens When You Stop Taking Saxenda

When you discontinue Saxenda, the medication's effects on appetite regulation and gastric emptying gradually diminish as the drug is cleared from your system. Liraglutide has a half-life of approximately 13 hours, meaning it takes around 2–3 days for the medication to be substantially eliminated from the body. During this period and in the weeks following cessation, several physiological and behavioural changes commonly occur.

Appetite and hunger typically return to pre-treatment levels relatively quickly after stopping Saxenda. Many patients report increased hunger, reduced satiety after meals, and stronger food cravings within the first week of discontinuation. This occurs because the GLP-1 receptor agonist effect that suppressed appetite signals is no longer present. The return of normal gastric emptying may also mean you feel less full after eating compared to when on treatment.

Weight regain is a significant concern after stopping GLP-1 receptor agonist treatments. Research indicates that many individuals regain a substantial portion of the weight lost during Saxenda treatment after stopping, particularly without continued lifestyle modifications. There is no official link between stopping Saxenda and any specific withdrawal syndrome, but the metabolic and hormonal changes that contributed to obesity often reassert themselves once pharmacological support is removed.

Other potential changes include:

• Blood glucose levels may rise slightly in those with prediabetes or type 2 diabetes

• Blood pressure and lipid profiles may worsen if weight is regained

• Psychological effects such as disappointment or anxiety about weight management

• Gastrointestinal symptoms typically resolve within days to weeks

If you have diabetes, it's particularly important to monitor your blood glucose more closely after stopping Saxenda and consult your healthcare team about potential adjustments to your diabetes medications.

It is important to monitor your weight, eating patterns, and any health parameters that improved during treatment. Contact your GP if you experience:

• Rapid or unexpected weight regain

• Worsening of weight-related health conditions

• Significant changes in mood or eating behaviours

• Any new or concerning symptoms

If you experience any side effects after stopping Saxenda, report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app).

How to Safely Come Off Saxenda

Discontinuing Saxenda does not require a gradual dose reduction or tapering schedule from a pharmacological perspective, as there is no evidence of physical dependence or withdrawal symptoms associated with stopping GLP-1 receptor agonists. However, a planned, supported approach to cessation can help minimise weight regain and maintain the health benefits achieved during treatment.

Before stopping Saxenda, consider the following steps:

1. Consult your prescribing clinician – discuss your reasons for stopping and ensure it is the appropriate time. Your doctor can assess whether continuing treatment might be beneficial or if alternative weight management strategies should be implemented.

2. Establish a weight maintenance plan – work with a healthcare professional, dietitian, or weight management service to develop a structured plan that includes:

• A balanced, calorie-controlled diet tailored to your maintenance energy needs

• Regular physical activity (UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity exercise weekly plus strength activities on two days)

• Behavioural strategies such as food diaries, meal planning, and mindful eating

• Regular self-monitoring of weight (weekly or fortnightly)

3. Address underlying behaviours – if you have not already done so, consider psychological support or cognitive behavioural therapy (CBT) to address emotional eating, food relationships, or other behavioural factors contributing to weight management challenges.

4. Optimise other health conditions – ensure that conditions such as type 2 diabetes, hypertension, or dyslipidaemia are well-controlled through medication, lifestyle, and regular monitoring.

5. Plan for ongoing support – arrange follow-up appointments with your GP or weight management service as agreed with your clinician to monitor weight, provide accountability, and adjust strategies as needed.

When to seek medical advice:

• If you experience unexpected symptoms after stopping

• If weight regain is rapid or exceeds your expectations

• If you wish to discuss restarting Saxenda or alternative treatments

• If weight-related health conditions deteriorate

• If you become pregnant (stop Saxenda immediately and inform your doctor)

Some patients may benefit from a phased approach, where they intensify lifestyle modifications in the weeks before stopping Saxenda to establish sustainable habits whilst still benefiting from appetite suppression.

Managing Weight After Stopping Saxenda

Maintaining weight loss after discontinuing Saxenda requires commitment to long-term lifestyle changes and, for many individuals, ongoing support. Weight regain is common but not inevitable, and evidence-based strategies can significantly improve the likelihood of sustained weight maintenance.

Dietary strategies for weight maintenance:

• Calorie awareness – understand your maintenance calorie needs and monitor intake through food diaries or apps

• Adequate protein – include protein-rich foods in your diet to help preserve muscle mass and promote satiety

• Whole foods focus – prioritise vegetables, fruits, whole grains, lean proteins, and healthy fats whilst limiting ultra-processed foods, sugary drinks, and high-calorie snacks

• Portion control – use smaller plates, be mindful of portion sizes, especially as appetite increases

• Regular meal patterns – establish consistent eating times and avoid prolonged periods without food, which can lead to overeating

Consider seeking advice from a registered dietitian for a personalised eating plan, particularly if you have other health conditions such as chronic kidney disease that may require specific dietary adjustments.

Physical activity recommendations:

Regular exercise is crucial for weight maintenance and metabolic health. UK Chief Medical Officers recommend:

• At least 150 minutes of moderate-intensity aerobic activity (e.g., brisk walking, cycling) per week

• Muscle-strengthening activities on at least two days per week

• Reduced sitting time and increased daily activity through active transport, taking stairs, and reducing sedentary time

Many people find they need more than the minimum 150 minutes of activity weekly to maintain weight loss successfully.

Behavioural and psychological strategies:

• Self-monitoring – regular weighing (weekly) and tracking of food intake and activity

• Goal setting – establish realistic, specific goals for weight maintenance and healthy behaviours

• Problem-solving – identify high-risk situations (stress, social events, holidays) and develop coping strategies

• Social support – engage family, friends, or support groups in your weight maintenance efforts

• Professional support – consider ongoing input from dietitians, exercise specialists, or psychologists

Alternative treatment options:

If weight regain occurs despite lifestyle efforts, discuss with your GP whether:

• Restarting Saxenda might be appropriate

• Other weight management medications could be considered (e.g., orlistat, which is more widely available on the NHS, or semaglutide/Wegovy under NICE TA875 criteria)

• Referral to specialist NHS weight management services is warranted (typically for BMI ≥35 kg/m² with complications or BMI ≥40 kg/m²)

• Assessment for bariatric surgery should be considered (according to NICE criteria)

Long-term monitoring should include:

• Regular weight checks and BMI calculation

• Blood pressure monitoring

• Blood tests for glucose, HbA1c, and lipid profiles as clinically indicated

• Assessment of weight-related comorbidities

Remember that weight management is a chronic condition requiring ongoing attention. Seeking help early if weight regain occurs, rather than waiting until significant weight is regained, improves the likelihood of successful intervention.

For more information, consult the NHS website, the British Dietetic Association resources on weight management, or speak with your healthcare team.

Frequently Asked Questions